Brimonidine Tartrate (Sandoz Inc)
Welcome to the PulseAid listing for the Brimonidine Tartrate drug offered from Sandoz Inc. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Brimonidine Tartrate |
| SUBSTANCE NAME: | BRIMONIDINE TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-10-02 |
| END MARKETING DATE: | 0000-00-00 |
Brimonidine Tartrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Brimonidine Tartrate from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/mL) |
| START MARKETING DATE: | 2010-10-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61314-144_d3bb4638-7801-4dd3-b923-23a7e5bb04ce |
| PRODUCT NDC: | 61314-144 |
| APPLICATION NUMBER: | NDA021764 |
Other BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers:
